Vicki Munro1, Manal Elnenaei2, Steve Doucette3, David B Clarke4, Syed Ali Imran5. 1. Division of Endocrinology, Department of Medicine, Dalhousie University, Saint John, NB, Canada. 2. Division of Clinical Chemistry, Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, NS, Canada. 3. Research Methods Unit, Nova Scotia Health Authority, Department of Community Health and Epidemiology, Halifax, NS, Canada. 4. Division of Neurosurgery, Department of Surgery, Dalhousie University, Halifax, NS, Canada; Division of Endocrinology, Department of Medicine, Dalhousie University, Halifax, NS, Canada. 5. Division of Endocrinology, Department of Medicine, Dalhousie University, Halifax, NS, Canada. Electronic address: ali.imran@nshealth.ca.
Abstract
BACKGROUND: Despite widespread use of the 250-mcg Cosyntropin test (ACTH test) for the diagnosis of adrenal insufficiency (AI), the effect of time of day and the utility of performing both 30- and 60-min serum cortisol values remains unclear. METHODS: We conducted a retrospective cohort study of all ACTH testing at the Halifax Neuropituitary Program, Nova Scotia, Canada between January 2006 and April 2016. Data were collected on age, gender, medication history, serum cortisol levels at 0, 30 and 60 min after ACTH administration, as well as time of and indication for testing. RESULTS: There were 336 tests performed, divided by time of day (0800-1000 h, 1001-1200 h, and after 1200 h). There were no differences in mean cortisol levels at 30 (574.5, 559, 534 nmol/L, respectively; p = 0.25) and 60 min (642, 623, 619 nmol/L, respectively; p = 0.63) between groups. When comparing 30- vs. 60-min values using a cut-off of ≥500 nmol/L, 45 patients (13.4%) failed to reach the cut-off at 30 min but met the cut-off at 60 min. Conversely, only 2 patients (0.6%) who met the cut-off at 30 min failed to reach it at 60 min. CONCLUSION: We found that outcomes from ACTH testing are not affected by time of day. Furthermore, using a 30-min cortisol level in isolation results in more than one in seven patients having a false positive diagnosis of AI; a 60-min value of ≥500 nmol/L alone may be sufficient to diagnose AI in >99% of cases.
BACKGROUND: Despite widespread use of the 250-mcg Cosyntropin test (ACTH test) for the diagnosis of adrenal insufficiency (AI), the effect of time of day and the utility of performing both 30- and 60-min serum cortisol values remains unclear. METHODS: We conducted a retrospective cohort study of all ACTH testing at the Halifax Neuropituitary Program, Nova Scotia, Canada between January 2006 and April 2016. Data were collected on age, gender, medication history, serum cortisol levels at 0, 30 and 60 min after ACTH administration, as well as time of and indication for testing. RESULTS: There were 336 tests performed, divided by time of day (0800-1000 h, 1001-1200 h, and after 1200 h). There were no differences in mean cortisol levels at 30 (574.5, 559, 534 nmol/L, respectively; p = 0.25) and 60 min (642, 623, 619 nmol/L, respectively; p = 0.63) between groups. When comparing 30- vs. 60-min values using a cut-off of ≥500 nmol/L, 45 patients (13.4%) failed to reach the cut-off at 30 min but met the cut-off at 60 min. Conversely, only 2 patients (0.6%) who met the cut-off at 30 min failed to reach it at 60 min. CONCLUSION: We found that outcomes from ACTH testing are not affected by time of day. Furthermore, using a 30-min cortisol level in isolation results in more than one in seven patients having a false positive diagnosis of AI; a 60-min value of ≥500 nmol/L alone may be sufficient to diagnose AI in >99% of cases.
Authors: Bradley R Javorsky; Hershel Raff; Ty B Carroll; Alicia Algeciras-Schimnich; Ravinder Jit Singh; Jessica M Colón-Franco; James W Findling Journal: J Endocr Soc Date: 2021-02-18
Authors: Ravikumar Ravindran; Joanne L Carter; Asit Kumar; Florin Capatana; Ishrat N Khan; Mohamed A Adlan; Lakdasa D Premawardhana Journal: Clin Med Insights Endocrinol Diabetes Date: 2022-05-06